Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Gallagher Carol Giltner Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 Gallagher Carol Giltner (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
Gifted 21,500 options to buy @ $5.59, valued at $120.2k
Gifted 21,500 options to buy @ $5.59, valued at $120.2k
06/02/2023 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 57,000 shares @ $0
Granted 79,500 options to buy @ $1.53, valued at $121.6k
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/08/2022 3 Gallagher Carol Giltner (Director) has filed a Form 3 on PMV Pharmaceuticals, Inc.
08/17/2022 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Disposed/sold 8,500 options to buy @ $65.39, valued at $555.8k
Disposed/sold 8,500 options to buy @ $65.64, valued at $557.9k
Disposed/sold 30,000 options to buy @ $39.99, valued at $1.2M
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Granted 8,500 options to buy @ $65.64, valued at $557.9k
12/17/2020 3/A Gallagher Carol Giltner (Director) has filed a Form 3/A on Frazier Lifesciences Acquisition Corp
12/08/2020 3 Gallagher Carol Giltner (Director) has filed a Form 3 on Frazier Lifesciences Acquisition Corp
09/15/2020 3 Gallagher Carol Giltner (Director) has filed a Form 3 on Metacrine, Inc.
07/23/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2019 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $39.99, valued at $1.2M
07/25/2019 3 Gallagher Carol Giltner (Director) has filed a Form 3 on Turning Point Therapeutics, Inc.
07/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2019 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Millendo Therapeutics, Inc.
Txns: Granted 12,000 options to buy @ $11.59, valued at $139.1k
01/17/2019 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Millendo Therapeutics, Inc.
Txns: Granted 6,000 options to buy @ $8.8, valued at $52.8k
12/11/2018 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Millendo Therapeutics, Inc.
Txns: Granted 8,249 shares @ $0
Granted 23,684 shares @ $0
12/11/2018 3 Gallagher Carol Giltner (Director) has filed a Form 3 on Millendo Therapeutics, Inc.
11/07/2018 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 21,374 shares @ $36.38, valued at $777.6k
06/19/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2018 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Granted 1,500 shares @ $0
Granted 5,000 options to buy @ $45.65, valued at $228.3k
05/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/20/2018 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,183 shares @ $46.5, valued at $55k
Exercised 1,548 restricted stock units @ $0
Exercised 817 restricted stock units @ $0
02/06/2018 4 Gallagher Carol Giltner (Director) has filed a Form 4 on ANAPTYSBIO INC
Txns: Granted 6,000 options to buy @ $104.81, valued at $628.9k
11/17/2017 4 Gallagher Carol Giltner (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns: Sold 1,184 shares @ $14.2, valued at $16.8k
Exercised 1,549 restricted stock units @ $0
Exercised 817 restricted stock units @ $0
08/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy